Mitesco Return on Tangible Equity 2015-2025 | MITI
Current and historical return on tangible equity values for Mitesco (MITI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Mitesco Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $0.00B | $-0.02B | -4.82% |
| 2025-03-31 | $0.00B | $-0.02B | 0.00% |
| 2024-12-31 | $0.00B | $-0.03B | 23.19% |
| 2024-09-30 | $0.00B | $-0.01B | -7.14% |
| 2024-06-30 | $0.00B | $-0.02B | 26.23% |
| 2024-03-31 | $-0.01B | $-0.02B | 68.75% |
| 2023-12-31 | $-0.02B | $-0.01B | 87.67% |
| 2023-09-30 | $-0.03B | $-0.02B | 148.72% |
| 2023-06-30 | $-0.03B | $-0.02B | 173.91% |
| 2023-03-31 | $-0.03B | $-0.02B | 189.09% |
| 2022-12-31 | $-0.02B | $-0.02B | 300.00% |
| 2022-09-30 | $-0.02B | $-0.01B | 566.67% |
| 2022-06-30 | $-0.02B | $0.00B | 1500.00% |
| 2022-03-31 | $-0.01B | $0.00B | -5200.00% |
| 2021-12-31 | $-0.01B | $0.00B | -1200.00% |
| 2021-09-30 | $-0.01B | $0.00B | 0.00% |
| 2021-06-30 | $-0.01B | $0.00B | 933.33% |
| 2021-03-31 | $-0.01B | $0.00B | 400.00% |
| 2020-12-31 | $0.00B | $0.00B | 120.00% |
| 2020-09-30 | $0.00B | $0.00B | 177.78% |
| 2020-06-30 | $0.00B | $0.00B | 177.78% |
| 2020-03-31 | $0.00B | $0.00B | 133.33% |
| 2019-12-31 | $0.00B | $0.00B | 133.33% |
| 2019-09-30 | $0.00B | $0.00B | 44.44% |
| 2019-06-30 | $0.00B | $0.00B | 57.14% |
| 2019-03-31 | $0.00B | $0.00B | 66.67% |
| 2018-12-31 | $0.00B | $0.00B | 80.00% |
| 2018-09-30 | $0.00B | $0.00B | 100.00% |
| 2018-06-30 | $0.00B | $0.00B | 0.00% |
| 2018-03-31 | $0.00B | $0.00B | 0.00% |
| 2017-12-31 | $0.00B | $0.00B | 0.00% |
| 2017-09-30 | $0.00B | $0.00B | 0.00% |
| 2017-06-30 | $0.00B | $0.00B | 200.00% |
| 2017-03-31 | $0.00B | $0.00B | 400.00% |
| 2016-12-31 | $-0.01B | $0.00B | 666.67% |
| 2016-06-30 | $0.00B | $0.00B | 1200.00% |
| 2016-03-31 | $0.00B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.002B | $0.000B |
| Mitesco Inc. is holding company for MyCare, LLC. It is building out a network of clinics using telehealth technology with the nurse practitioner operating as its primary healthcare provider. Mitesco Inc., formerly known as True Nature Holding Inc., is based in Denver, CO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.128B | 58.69 |
| Tempus AI (TEM) | United States | $13.327B | 0.00 |
| Doximity (DOCS) | United States | $12.012B | 53.44 |
| Hims & Hers Health (HIMS) | United States | $9.936B | 81.41 |
| IRhythm Technologies (IRTC) | United States | $5.355B | 0.00 |
| Hinge Health (HNGE) | United States | $4.369B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.710B | 39.83 |
| Privia Health (PRVA) | United States | $2.618B | 193.91 |
| Heartflow (HTFL) | $2.348B | 0.00 | |
| Phreesia (PHR) | United States | $1.711B | 0.00 |
| Enovis (ENOV) | United States | $1.686B | 8.91 |
| 10x Genomics (TXG) | United States | $1.631B | 0.00 |
| Omnicell (OMCL) | United States | $1.465B | 28.22 |
| Schrodinger (SDGR) | United States | $1.441B | 0.00 |
| Azenta (AZTA) | United States | $1.368B | 59.68 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Claritev (CTEV) | United States | $1.131B | 0.00 |
| Evolent Health (EVH) | United States | $1.030B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.655B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.580B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.458B | 0.00 |
| Talkspace (TALK) | United States | $0.456B | 136.00 |
| Butterfly Network (BFLY) | United States | $0.350B | 0.00 |
| Carlsmed (CARL) | United States | $0.342B | 0.00 |
| TruBridge (TBRG) | United States | $0.296B | 51.87 |
| Outset Medical (OM) | United States | $0.243B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.232B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.216B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.190B | 0.00 |
| CapsoVision (CV) | United States | $0.186B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.145B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.121B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 5.23 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.071B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.037B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Zhongchao (ZCMD) | China | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| PROFUSA (PFSA) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |